Published on in Vol 14 (2025)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/64899, first published
.
Effect of Adherence to Oral Semaglutide on Glycemic Control in People With Type 2 Diabetes Treated With Metformin: Protocol for an Open-Label Clinical Trial
Effect of Adherence to Oral Semaglutide on Glycemic Control in People With Type 2 Diabetes Treated With Metformin: Protocol for an Open-Label Clinical Trial
Journals
- Ahmed U, Baker J, Rosenberg J, Reistrup H. Turning a nation into a cohort: combining national registers and a digital mailbox for population-based health research. European Journal of Epidemiology 2026 View
- Prakash S, Dhama N, Kumar A. Optimizing Semaglutide Therapy in Type 2 Diabetes: Pharmacokinetic Limitations, Nanoemulsion-Based Delivery Strategies and Translational Potential. Journal of Pharmaceutical Innovation 2027;22(1) View
- Xu M, Song W, Lv F, Fu Y, Yang L, Bin X, Zhang X, Ye Z, Zhang D, Lin X, Dai W, Shu C, Yan L. Efficacy and safety of HRS-7535, a novel oral small-molecule glucagon-like peptide-1 receptor agonist, in participants with type 2 diabetes mellitus inadequately controlled by metformin and sodium–glucose co-transporter 2 inhibitors: a multicentre, randomised, double-blind, placebo-controlled, parallel-group Phase II trial. Diabetologia 2026 View